Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.
Blood Adv. 2023 Jun 13;7(11):2360-2363. doi: 10.1182/bloodadvances.2022008625.
Blood Adv. 2023.
PMID: 36315007
Free PMC article.
Clinical Trial.
No abstract available.
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Cai SF, Huang Y, Lance JR, Mao HC, Dunbar AJ, McNulty SN, Druley T, Li Y, Baer MR, Stock W, Kovacsovics T, Blum WG, Schiller GJ, Olin RL, Foran JM, Litzow M, Lin T, Patel P, Foster MC, Boyiadzis M, Collins RH, Chervin J, Shoben A, Vergilio JA, Heerema NA, Rosenberg L, Chen TL, Yocum AO, Druggan F, Marcus S, Stefanos M, Druker BJ, Mims AS, Borate U, Burd A, Byrd JC, Levine RL, Stein EM.
Cai SF, et al. Among authors: yocum ao.
Blood Adv. 2024 Jan 23;8(2):429-440. doi: 10.1182/bloodadvances.2023010563.
Blood Adv. 2024.
PMID: 37871309
Free PMC article.
Item in Clipboard
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Duong VH, Ruppert AS, Mims AS, Borate U, Stein EM, Baer MR, Stock W, Kovacsovics T, Blum W, Arellano ML, Schiller GJ, Olin RL, Foran JM, Litzow MR, Lin TL, Patel PA, Foster MC, Redner RL, Al-Mansour Z, Cogle CR, Swords RT, Collins RH, Vergilio JA, Heerema NA, Rosenberg L, Yocum AO, Marcus S, Chen T, Druggan F, Stefanos M, Gana TJ, Shoben AB, Druker BJ, Burd A, Byrd JC, Levine RL, Boyiadzis MM.
Duong VH, et al. Among authors: yocum ao.
Cancer. 2023 Aug 1;129(15):2308-2320. doi: 10.1002/cncr.34780. Epub 2023 Apr 20.
Cancer. 2023.
PMID: 37078412
Clinical Trial.
Item in Clipboard
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system.
Byrd JC, Gatz JL, Louis CL, Mims AS, Borate U, Yocum AO, Gana TJ, Burd A.
Byrd JC, et al. Among authors: yocum ao.
Cancer Med. 2023 Sep;12(17):18368-18380. doi: 10.1002/cam4.6442. Epub 2023 Aug 28.
Cancer Med. 2023.
PMID: 37635639
Free PMC article.
Item in Clipboard
A tissue-specific chromatin loop activates the erythroid ankyrin-1 promoter.
Yocum AO, Steiner LA, Seidel NE, Cline AP, Rout ED, Lin JY, Wong C, Garrett LJ, Gallagher PG, Bodine DM.
Yocum AO, et al.
Blood. 2012 Oct 25;120(17):3586-93. doi: 10.1182/blood-2012-08-450262. Epub 2012 Sep 11.
Blood. 2012.
PMID: 22968456
Free PMC article.
Item in Clipboard
Cite
Cite